CHICAGO – The National Museum for Mexican Art is set to receive $750,000 to make improvements and create new exhibits, thanks to support from Assistant Majority Leader Tony Munoz (D-Chicago).
“Museums give people an experience to learn and understand our history,” Munoz said. “The National Museum for Mexican Art is extraordinary with rich visuals and eccentric exhibits. This funding will expand the museum’s arts for visitors from all over to enjoy.”
Read more: National Museum for Mexican Art awarded funding with support from Munoz
CHICAGO – To revitalize the community while prioritizing businesses and affordable housing, Back of the Yards Neighborhood Council will receive nearly $1.5 million, Assistant Majority Leader Tony Munoz (D-Chicago) announced Tuesday.
The Back of the Yards Neighborhood Council is a not-for-profit community organization serving a large area of Chicago’s Southwest Side, including the communities of Brighton Park, McKinley Park and New City. BYNC was created in response to growing social issues, including social disorganization, unemployment, poor housing, and juvenile delinquency, and continues today to organize residents and bring social services and economic resources to the community.
Read more: Munoz announces funding for local organization to revitalize community
SPRINGFIELD – To prioritize the safety of first responders, Assistant Majority Leader Tony Munoz (D-Chicago) championed new requirements drivers must adhere to when approaching an emergency vehicle on the side of the road
“First responders prioritize Illinois residents’ safety every day,” Munoz said. “We need to come together to protect the individuals on the front line who are assisting roadside emergencies. Slow down and move over when approaching any vehicle on the side of the road.”
Read more: Munoz strengthens Scott’s Law to protect first responders
SPRINGFIELD – Registration fees for small trailers will be $36, a significant decrease from the current $118, thanks to a measure sponsored by Assistant Majority Leader Tony Munoz (D-Chicago) that was signed into law today.
“A lot of good times start with a trailer, and especially after the year Illinoisans have had, it’s a great time to lower the up-front cost,” Munoz said. “The previous amount was extremely high, and now people can spend that money on any of the fun activities they’re going to use that trailer for, rather than on the fee.”
The new law classifies all trailers weighing 2,000 pounds or less as “utility trailers” and sets the utility trailer registration fee at $36. Fees were increased on these trailers in 2019 as a part of the Rebuild Illinois capital infrastructure plan.
SPRINGFIELD - Biomarker testing — the medical technology used to determine medical risk factors like cancer — will be covered under state-regulated insurance plans, thanks to a measure sponsored by Assistant Majority Leader Tony Munoz (D-Chicago) that was signed into law today.
“Patients looking to find answers about their health issues will now be able to without worrying about the costs,” Munoz said. “State-regulated insurance plans will cover biomarker testing, which helps figure out the right treatment at the right time to improve the quality of life for patients.”
Read more: New Munoz law makes genetic medical testing more accessible
CHICAGO – Assistant Majority Leader Tony Munoz (D-Chicago) has been appointed to the Illinois Veteran’s Advisory Council to address significant issues and concerns of Illinois veterans.
“As a veteran, I am proud to be appointed to the Veteran’s Advisory Council,” Munoz said. “One of my top priorities as a legislator has always been to protect and support veterans. I will continue to work with my colleagues to ensure veterans are taken care of.”
The council is empowered to review and study the issues and concerns that are most significant to Illinois veterans and advise the Illinois Department of Veterans Affairs on how to address the issues and concerns.
SPRINGFIELD – Biomarker testing — the medical technology used to determine medical risk factors like cancer — would be covered under state-regulated insurance plans under a measure sponsored by Assistant Majority Leader Tony (D-Chicago), which passed the Senate Tuesday.
“Inequalities exist in our health care services, especially for communities of color and people with lower income,” Munoz said. “Everyone deserves the right to benefit from this testing that can lead to better health outcomes, and this is essential for our fight against inequalities in our health care services.”
A “biomarker” is a sign of disease or abnormal function that can be measured in blood, tissue or bodily fluid. In cancer care, biomarkers are often used to help determine the best treatment for a patient. Biomarker testing analyzes a patient’s tissue, blood or other biospecimen for the presence of a biomarker.
Read more: Munoz advances plan to make genetic medical testing more accessible
SPRINGFIELD – Biomarker testing — the medical technology used to determine medical risk factors like cancer — would be required coverage under state-regulated insurance plans under a measure sponsored by Assistant Majority Leader Tony (D-Chicago), which was approved by the Senate Insurance Committee Wednesday.
“Many communities of color and people with lower income are less likely to have insurance plans that offer biomarker testing,” Munoz said. “We need to ensure that these medical advancements are not just for the rich and privileged. Everyone should be able to benefit from this technology.”
A “biomarker” is a sign of disease or abnormal function that can be measured in blood, tissue or bodily fluid. In cancer care, biomarkers are often used to help determine the best treatment for a patient. Biomarker testing analyzes a patient’s tissue, blood or other biospecimen for the presence of a biomarker.
Insurance coverage for biomarker testing is currently limited and disparate, a fact Munoz said leads to inequities in care for cancer patients.
House Bill 1779 requires group and individual accident and health insurance policies and managed care plans to include coverage for biomarker testing for the purposes of diagnosis and treatment.
“This legislation is going to lead to better health outcomes, an improved quality of life, and lower costs for the patients who most need this kind of care,” Munoz said. “It’s key to reducing health disparities for all patients, especially for lower income people.”
House Bill 1779 passed the Senate Insurance Committee and now heads to the Senate floor for further consideration.
Page 2 of 5